Refine Results
- 必威体育赛事投注
- Content Type
- Analysis Platform
- Language
1 - 13 of 13 results
Applied Filters
必威体育登录手机Agilent Technologies – building upon Stratagene's legacy of excellence – provides a wide range of high-fidelity, specialty, and routine enzymes built to meet virtually every amplification need.必威体育登录手机Agilent's PCR portfolio solution goes beyond the...
Instruction manual for the academic version of QuikChange Lightning Multi Site-Directed Mutagenesis Kit with introduction, guidelines and protocol requirements.
Materials, mutagenic primer design, mutant strand synthesis reaction, Dpn1 digestion, transformation of XL10-Gold Ultracompetent Cells.
Instruction manual for the commercial version of QuikChange Lightning Multi Site-Directed Mutagenesis Kit with introduction, guidelines and protocol requirements.
必威体育赛事投注Materials, mutagenic primer design, mutant strand synthesis reaction, Dpn I digestion of amplification products, transformation of XL1-Blue Supercompetent Cells.
Commercial: QuikChange multi mutagenesis control, mutagenic primer design, mutant strand synthesis reaction, Dpn I digestion, transformation guidelines, and troubleshooting.
QuikChange II-E Site-Directed Mutagenesis Kit
Mutagenic primer design, mutant strand synthesis reaction, thermal cycling, Dpn I digestion, transformation of XL10-Gold Ultracompetent Cells, transformation guidelines.
Academic, QuikChange multi mutagenesis control, mutagenic primer design, mutant strand synthesis reaction, Dpn I digestion, transformation guidelines, and troubleshooting.
必威体育赛事投注Mutagenic primer design, mutant strand synthesis reaction, thermal cycling, Dpn I digestion of amplification products, transformation of XL1-Blue Supercompetent Cells.
Instructions for the QuikChange Lightning Site-Directed Mutagenesis Kit with detailed requirements, protocols, and transformation guides.
Reliable next-generation mutagenesis and cloning tools
Mutational spectrum, amplification targets, initial amount of target DNA, cycle number, primer design, PCR product yield, achieving high mutation frequencies.